Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010–2020)
Y Li, S Sang, W Ren, Y Pei, Y Bian, Y Chen… - European journal of …, 2021 - Elsevier
Alzheimer's disease (AD) is one of the most common neurodegenerative disorders, which is
characterized by the primary risk factor, age. Several attempts have been made to treat AD …
characterized by the primary risk factor, age. Several attempts have been made to treat AD …
Tumor-associated macrophages in bladder cancer: biological role, impact on therapeutic response and perspectives for immunotherapy
MM Leblond, H Zdimerova, E Desponds, G Verdeil - Cancers, 2021 - mdpi.com
Simple Summary Tumor-associated macrophages (TAMs) play major roles in solid tumor
development. They can have both anti-tumor and pro-tumor properties depending on their …
development. They can have both anti-tumor and pro-tumor properties depending on their …
Pharmacological properties of trichostatin A, focusing on the anticancer potential: A comprehensive review
A Bouyahya, N El Omari, M Bakha, T Aanniz… - Pharmaceuticals, 2022 - mdpi.com
Trichostatin A (TSA), a natural derivative of dienohydroxamic acid derived from a fungal
metabolite, exhibits various biological activities. It exerts antidiabetic activity and reverses …
metabolite, exhibits various biological activities. It exerts antidiabetic activity and reverses …
Combination of microtubule targeting agents with other antineoplastics for cancer treatment
T Liang, L Lu, X Song, J Qi, J Wang - … et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
Microtubule targeting agents (MTAs) have attracted extensive attention for cancer treatment.
However, their clinical efficacies are limited by intolerable toxicities, inadequate efficacy and …
However, their clinical efficacies are limited by intolerable toxicities, inadequate efficacy and …
Can epigenetics of endothelial dysfunction represent the key to precision medicine in type 2 diabetes mellitus?
C Coco, L Sgarra, MA Potenza, C Nacci… - International Journal of …, 2019 - mdpi.com
In both developing and industrialized Countries, the growing prevalence of Type 2 Diabetes
Mellitus (T2DM) and the severity of its related complications make T2DM one of the most …
Mellitus (T2DM) and the severity of its related complications make T2DM one of the most …
[HTML][HTML] HDAC inhibitor Trichostatin A suppresses adipogenesis in 3T3-L1 preadipocytes
X Lv, J Qiu, T Hao, H Zhang, H Jiang, Y Tan - Aging (Albany NY), 2021 - ncbi.nlm.nih.gov
Background and purpose: Obesity is becoming a major global health issue and is mainly
induced by the accumulation of adipose tissues mediated by adipogenesis, which is …
induced by the accumulation of adipose tissues mediated by adipogenesis, which is …
The deubiquitinating enzyme inhibitor PR-619 enhances the cytotoxicity of cisplatin via the suppression of anti-apoptotic Bcl-2 protein: in vitro and in vivo study
After chemotherapy for the treatment of metastatic bladder urothelial carcinoma (UC), most
patients inevitably encounter drug resistance and resultant treatment failure …
patients inevitably encounter drug resistance and resultant treatment failure …
[HTML][HTML] Neddylation inhibitor, MLN4924 suppresses angiogenesis in huvecs and solid cancers: in vitro and in vivo study
CS Shi, KL Kuo, WC Lin, MS Chen, SH Liu… - American journal of …, 2020 - ncbi.nlm.nih.gov
Cullin-RING E3 ligases are involved in the ubiquitination of substrates that regulate
important biological processes and are a potential therapeutic target in many types of …
important biological processes and are a potential therapeutic target in many types of …
NIPSNAP protein family emerges as a sensor of mitochondrial health
Since their discovery over two decades ago, the molecular and cellular functions of the
NIPSNAP family of proteins (NIPSNAPs) have remained elusive until recently. NIPSNAPs …
NIPSNAP family of proteins (NIPSNAPs) have remained elusive until recently. NIPSNAPs …
Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing Bcl-xL: an in vitro and in vivo …
Cisplatin-based chemotherapy is the primary treatment for metastatic bladder urothelial
carcinoma (UC). Most patients inevitably encounter drug resistance and resultant disease …
carcinoma (UC). Most patients inevitably encounter drug resistance and resultant disease …